Drawing for SYNAPTAN

USPTO serial 79032294

SYNAPTAN

Reviewed by CopyMark Law Group

Reg. 3423093Status 404
Filing date
Status date
Registration date
May 6, 2008
Examiner
GLASSER, CARYN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SYNAPTAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Perfumery, essential oils, cosmetics, hair lotionsSECTION 71 - CANCELLED—
005Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of gastrointestinal diseases, laxatives and purgative agents; pharmaceutical preparations for in use in the treatment of cardiovascular diseases, circulatory disorders, cancer, neurological diseases, orthopedic disorders, urological diseases, hormonal disorders; pharmaceutical preparations for use in the treatment of blood diseases; pharmaceutical preparations for the treatment of diabetes and diabetes-related disorders; pharmaceutical preparations for the treatment of ophthalmological disorders; pharmaceutical preparations for the treatment of age-related disorders; pharmaceutical preparations for the treatment of cough; pharmaceutical preparations for use in the treatment of muscle disorders; pharmaceutical preparations for cosmetic purposes for the treatment of frown lines and other facial wrinkles, human skin and of imbalances and defects therein; pharmaceutical preparations for use in cosmetic surgery; pharmaceutical preparations for the treatment of pain, muscle spasm, hemifacial spasm, blepharospasm, dystonia, torticollis, cerebral palsy, articular pathologies, acne, headache, migraine, hyperhydrosis, myofascial pain, and hyperfunctional facial lines; pharmaceutical preparations for the treatment of frown lines and other facial wrinkles, human skin and of imbalances and defects therein; pharmaceutical preparations for the treatment of dermatological disorders namely scars and psoriasis ; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for the treatment of frown lines and other facial wrinkles, human skin and of imbalances and defects therein; Veterinary preparations, namely, veterinary preparations for use in the treatment of gastrointestinal diseases, laxatives and purgative agents; veterinary preparations for use in the treatment of cardiovascular diseases and circulatory disorders; veterinary preparations for use in the treatment of neurological diseases; veterinary preparations for use in the treatment of urological diseases; veterinary preparations for use in the treatment of hormonal disorders; veterinary preparations for use in the treatment of blood diseases; veterinary preparations for use in the treatment of muscle disorders, all for use in domestic or farm animalsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2017UNDNUNDELIVERABLE MAIL - NO ACTION TAKEN—
May 26, 2017DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
May 26, 2017DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 24, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 2, 2015INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 2, 2015INPCINVALIDATION PROCESSED—
Aug 12, 2015INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 12, 2014C71TCANCELLED SECTION 71—
May 13, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 12, 2009NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 22, 2009CHLDCHANGE OF OWNER RECEIVED FROM IB—
Aug 22, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 22, 2008FIMPFINAL DISPOSITION PROCESSED—
Aug 6, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 6, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 19, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2008NPUBNOTICE OF PUBLICATION—
Jan 15, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 14, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 2008CNEAEXAMINERS AMENDMENT MAILED—
Jan 11, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Jan 11, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 10, 2007ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 3, 2007PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Nov 20, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 20, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 25, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 25, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 25, 2007ALIEASSIGNED TO LIE—
Sep 17, 2007MAILPAPER RECEIVED—
Mar 29, 2007RFNTREFUSAL PROCESSED BY IB—
Mar 13, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 13, 2007RFRRREFUSAL PROCESSED BY MPU—
Mar 11, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 10, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2007DOCKASSIGNED TO EXAMINER—
Dec 22, 2006NWAPNEW APPLICATION ENTERED—
Dec 21, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance